tldrdailynews.com logo

HPV Vaccine Slashes Cervical Cancer Risk in Long-Term Swedish Study

1 min read
Source: ScienceAlert
HPV Vaccine Slashes Cervical Cancer Risk in Long-Term Swedish Study
Photo: ScienceAlert
TL;DR

A Swedish nationwide study following nearly a million girls and young women for up to 18 years shows the HPV vaccine substantially lowers cervical cancer risk, especially when given before age 17, with protection persisting for at least 18 years and supporting gender-neutral vaccination programs.

Topics:health#cervical-cancer#health#hpv#long-term-study#sweden#vaccination
Share this article
  1. Vaccine Cuts Risk of Common Cancer For Decades, Major Study Finds  ScienceAlert
  2. The shot that could stop cancer before it begins – and why getting it early matters  The Conversation
  3. The Biggest Challenge in HPV Vaccination  Targeted Oncology
  4. HPV vaccine slashes cervical cancer risk: study  NewsBytes
  5. PH advances cervical cancer prevention with Data-Driven HPV Vaccine Strategy  SunStar Publishing Inc.

Want the full story? Read the original reporting

Read on ScienceAlert